GLP-1 Injections are used to help individuals with obesity or overweight manage their weight by affecting hunger, satiety, and insulin production, leading to a reduction in food intake and improved metabolic control
The vitamins contained contribute to normal energy metabolism, nervous system function, maintenance of psychological state, reduction of fatigue, and immune system activity
Allergic Eczema: Burn-like and often found on the forearms and hands
Semaglutide acts on GLP-1 receptors in the hypothalamusthe brain region responsible for regulating hunger and satiety signals
Other reported or anticipated side effects based on Phase 2 data and the known pharmacology of the drug class include: Injection site reactions redness, bruising, or mild discomfort at the site of subcutaneous injection Fatigue commonly associated with caloric restriction and rapid weight loss Headache reported with GLP-1 receptor agonists as a class Increased heart rate (tachycardia) a known class effect of GLP-1 receptor agonists
Research Citations Jensen, L., Helleberg, H., Roffel, A., van Lier, J